Indication
Kidney Transplantation in Highly Sensitized Patients
1 clinical trial
1 product
Product
ImlifidaseClinical trial
An Open Label, Phase II Study to Investigate DSA Rebound in Patients With a Positive Crossmatch, Made Transplantable With ImlifidaseStatus: Active (not recruiting), Estimated PCD: 2024-03-01